China, Sept. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Sivelestat Sodium in Patients with Acute Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131960
Registration Time: 2026/09/08
Type: Interventional study
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333229
Published by HT Digital Content Services with permission from Health Daily Digest....